Corporate report

Commissioning impact on drug treatment

This report by the Advisory Council on the Misuse of Drugs (ACMD) investigates the impact on drug treatment.


Commissioning impact on drug treatment

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


This independent report by the ACMD investigates the impact of commissioning on drug treatment.

It looks at:

  • commissioning structures
  • contracting arrangements and the financial environment
  • the impact on recovery outcomes for individuals and communities
Published 6 September 2017